Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Definium Therapeutics closed its upsized public offering, raising $805 million in gross proceeds by selling 23.7 million shares at a price of $34.00 per share. The offering included the full exercise of the underwriters' option to purchase an additional 3.1 million shares, signaling robust investor demand for the capital raise.
Key figures
- Deal Value Usd
- 805000000
- Offering Price
- 34
- Shares Offered
- 23676471
- Drug name
- DT120 ODT
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.